Farther Finance Advisors, LLC Arvinas, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.77 Trillion
- Q4 2024
A detailed history of Farther Finance Advisors, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 89 shares of ARVN stock, worth $1,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89
Previous 114
21.93%
Holding current value
$1,629
Previous $2.81 Million
39.25%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.53MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$129 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$123 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$115 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$75.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$61.1 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $974M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...